Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Cancer|August 16, 2006
A phase II study of gemcitabine and capecitabine in metastatic renal cancer: a report of Cancer and Leukemia Group B protocol 90008Walter M Stadler, Susan Halabi, Brian Rini, et al.
AJR. American Journal of Roentgenology|April 24, 2007
Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumorsAlexander S Ho, Joel Picus, Michael D Darcy, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 24, 2005
Positron tomographic assessment of androgen receptors in prostatic carcinomaFarrokh Dehdashti, Joel Picus, Jeff M Michalski, et al.
Oncology|December 6, 2003
Phase II study of gemcitabine plus docetaxel in advanced pancreatic cancer: a Hoosier Oncology Group studyBryan P Schneider, Kristen N Ganjoo, David E Seitz, et al.
Investigational New Drugs|July 10, 2007
Phase II study of KOS-862 in patients with metastatic androgen independent prostate cancer previously treated with docetaxelTomasz M Beer, Celestia S Higano, Mansoor Saleh, et al.
Cancer|September 29, 2011
Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancerPhilip A Philip, Michelle R Mahoney, Kyle D Holen, et al.
Cancer|September 24, 2010
A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate-resistant prostate cancer: results from Cancer and Leukemia Group B Study 90006Joel Picus, Susan Halabi, W Kevin Kelly, et al.
American Journal of Clinical Oncology|June 1, 2005
A phase II study of alternating cycles of split course radiation therapy and gemcitabine chemotherapy for inoperable pancreatic or biliary tract carcinomaLilie L Lin, Joel Picus, J A Drebin, et al.
International Journal of Molecular Sciences|June 12, 2026
Exploratory FDG PET/CT Imaging in mCRPC Patients Treated with Sipuleucel-T ± IL-7: A Phase II Trial SubanalysisSandeep Surendra Panikar, Dhruv Bansal, John Crandall, et al.
The Oncologist|January 3, 2012
Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier Oncology Group GI06-101E Gabriela Chiorean, Rashmi Ramasubbaiah, Menggang Yu, et al.
Pageof 10